Wanda Salzer

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407
    Wanda L Salzer
    Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA
    Pediatr Blood Cancer 59:834-9. 2012
  2. pmc Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Wanda L Salzer
    NCI IRB, Building 82, Room 215, MSC 8200, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 34:e1-7. 2012
  3. doi request reprint Analysis of infectious complications in infants with acute lymphoblastic leukemia treated on the Children's Cancer Group Protocol 1953: a report from the Children's Oncology Group
    Wanda Salzer
    National Cancer Institute, NIH, NCI IRB, 9030 Old Georgetown Road, Building 82, Room 215, MSC 8200, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:398-405. 2009
  4. doi request reprint Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group
    W L Salzer
    National Cancer Institute, Bethesda, MD 20892, USA
    Leukemia 24:355-70. 2010

Detail Information

Publications4

  1. doi request reprint Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407
    Wanda L Salzer
    Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA
    Pediatr Blood Cancer 59:834-9. 2012
    ..Infants (<366 days of age) with acute lymphoblastic leukemia (ALL) have a poor prognosis. Most treatment failures occur within 6-9 months of diagnosis, primarily from relapse...
  2. pmc Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Wanda L Salzer
    NCI IRB, Building 82, Room 215, MSC 8200, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 34:e1-7. 2012
    ..7 μM, compared with non-Hispanic children, 9.95 μM (P=0.0015), but this did not correlate with a difference in outcome. Neither RBC MTX, RBC folate, nor the RBC MTX:folate ratio identified children at increased risk of failure...
  3. doi request reprint Analysis of infectious complications in infants with acute lymphoblastic leukemia treated on the Children's Cancer Group Protocol 1953: a report from the Children's Oncology Group
    Wanda Salzer
    National Cancer Institute, NIH, NCI IRB, 9030 Old Georgetown Road, Building 82, Room 215, MSC 8200, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:398-405. 2009
    ....
  4. doi request reprint Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group
    W L Salzer
    National Cancer Institute, Bethesda, MD 20892, USA
    Leukemia 24:355-70. 2010
    ..Only gender was prognostic in T-cell ALL. In infants, WBC and MLL translocation were linked to inferior outcome...